| Epidermal growth factor-related peptides and their receptors in human malignancies DS Salomon, R Brandt, F Ciardiello, N Normanno Critical reviews in oncology/hematology 19 (3), 183-232, 1995 | 3792 | 1995 |
| ESMO consensus guidelines for the management of patients with metastatic colorectal cancer E Van Cutsem, A Cervantes, R Adam, A Sobrero, JH Van Krieken, ... Annals of Oncology 27 (8), 1386-1422, 2016 | 3703 | 2016 |
| Epidermal growth factor receptor (EGFR) signaling in cancer N Normanno, A De Luca, C Bianco, L Strizzi, M Mancino, MR Maiello, ... Gene 366 (1), 2-16, 2006 | 2569 | 2006 |
| Endocrine therapy plus zoledronic acid in premenopausal breast cancer M Gnant, B Mlineritsch, W Schippinger, G Luschin-Ebengreuth, ... New England Journal of Medicine 360 (7), 679-691, 2009 | 1291 | 2009 |
| Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group F Mosele, J Remon, J Mateo, CB Westphalen, F Barlesi, MP Lolkema, ... Annals of Oncology 31 (11), 1491-1505, 2020 | 1065 | 2020 |
| Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up☆ A Cervantes, R Adam, S Roselló, D Arnold, N Normanno, J Taïeb, ... Annals of Oncology 34 (1), 10-32, 2023 | 870 | 2023 |
| The RAS/RAF/MEK/ERK and the PI3K/AKT signalling pathways: role in cancer pathogenesis and implications for therapeutic approaches A De Luca, MR Maiello, A D'Alessio, M Pergameno, N Normanno Expert opinion on therapeutic targets 16 (sup2), S17-S27, 2012 | 839 | 2012 |
| KRAS, BRAF, PIK3CA, and PTEN mutations: implications for targeted therapies in metastatic colorectal cancer W De Roock, V De Vriendt, N Normanno, F Ciardiello, S Tejpar The lancet oncology 12 (6), 594-603, 2011 | 716 | 2011 |
| Implications for KRAS status and EGFR-targeted therapies in metastatic CRC N Normanno, S Tejpar, F Morgillo, A De Luca, E Van Cutsem, F Ciardiello Nature reviews Clinical oncology 6 (9), 519-527, 2009 | 528 | 2009 |
| Target-based agents against ErbB receptors and their ligands: a novel approach to cancer treatment. N Normanno, C Bianco, A De Luca, MR Maiello, DS Salomon Endocrine-related cancer 10 (1), 1-21, 2003 | 484 | 2003 |
| The role of the EGFR signaling in tumor microenvironment A De Luca, A Carotenuto, A Rachiglio, M Gallo, MR Maiello, D Aldinucci, ... Journal of cellular physiology 214 (3), 559-567, 2008 | 470 | 2008 |
| The ErbB receptors and their ligands in cancer: an overview N Normanno, C Bianco, L Strizzi, M Mancino, MR Maiello, AD Luca, ... Current drug targets 6 (3), 243-257, 2005 | 389 | 2005 |
| Mechanisms of endocrine resistance and novel therapeutic strategies in breast cancer N Normanno, M Di Maio, E De Maio, A De Luca, A de Matteis, A Giordano, ... Endocrine-related cancer 12 (4), 721-747, 2005 | 381 | 2005 |
| ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group J Pascual, G Attard, FC Bidard, G Curigliano, L de Mattos-Arruda, ... Annals of Oncology 33 (8), 750-768, 2022 | 376 | 2022 |
| Implementing TMB measurement in clinical practice: considerations on assay requirements R Büttner, JW Longshore, F López-Ríos, S Merkelbach-Bruse, ... ESMO open 4 (1), e000442, 2019 | 351 | 2019 |
| Cooperative inhibitory effect of ZD1839 (Iressa) in combination with trastuzumab (Herceptin) on human breast cancer cell growth N Normanno, M Campiglio, A De Luca, G Somenzi, M Maiello, ... Annals of Oncology 13 (1), 65-72, 2002 | 350 | 2002 |
| Tyrosine kinase inhibitors of vascular endothelial growth factor receptors in clinical trials: current status and future directions A Morabito, E De Maio, M Di Maio, N Normanno, F Perrone The oncologist 11 (7), 753-764, 2006 | 347 | 2006 |
| Leptin signaling in breast cancer: an overview D Cirillo, AM Rachiglio, R La Montagna, A Giordano, N Normanno Journal of cellular biochemistry 105 (4), 956-964, 2008 | 309 | 2008 |
| The role of EGF-related peptides in tumor growth N Normanno, C Bianco, A De Luca, DS Salomon Front Biosci 6 (1), D685-707, 2001 | 299 | 2001 |
| Delivering precision oncology to patients with cancer J Mateo, L Steuten, P Aftimos, F André, M Davies, E Garralda, J Geissler, ... Nature medicine 28 (4), 658-665, 2022 | 276 | 2022 |
